HomeInsightsStock Comparison

Accretion Pharmaceuticals Ltd vs Bliss Gvs Pharma Ltd Stock Comparison

Accretion Pharmaceuticals Ltd vs Bliss Gvs Pharma Ltd Stock Comparison

Last Updated on: May 27, 2025

Key Highlights

  • The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 67.6 as of 27 May 15:30.
  • The P/E Ratio of Accretion Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Bliss GVS Pharma Ltd changed from 10.7 on March 2020 to 15.6 on March 2024 . This represents a CAGR of 7.83% over 5 years.
  • The Market Cap of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1039 crore on March 2020 to ₹ 1179 crore on March 2024 . This represents a CAGR of 2.55% over 5 years.
  • The revenue of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bliss GVS Pharma Ltd for the Mar '25 is ₹ 210.05 crore as compare to the Dec '24 revenue of ₹ 225.68 crore. This represent the decline of -6.93%.
  • The ebitda of Accretion Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bliss GVS Pharma Ltd for the Mar '25 is ₹ 33.15 crore as compare to the Dec '24 ebitda of ₹ 45.05 crore. This represent the decline of -26.42%.
  • The net profit of Accretion Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Bliss GVS Pharma Ltd changed from ₹ 14.37 crore to ₹ 16.65 crore over 8 quarters. This represents a CAGR of 7.64% .
  • The Dividend Payout of Accretion Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bliss GVS Pharma Ltd changed from 5.58 % on March 2020 to 10.34 % on March 2024 . This represents a CAGR of 13.13% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Accretion Pharmaceuticals Ltd

  • Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
  • Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014.
  • Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
  • The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
  • It has a strong foothold in Sub Saharan Africa.
  • The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Accretion Pharmaceuticals Ltd News Hub

News

NSE SME Accretion Pharma stumbles on market debut

The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price...

Read more

21 May 2025 10:38

News

NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times

The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 ...

Read more

19 May 2025 11:43

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma schedules AGM

Bliss GVS Pharma announced that the 40th Annual General Meeting(AGM) of the company will b...

Read more

13 May 2025 12:51

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

13 May 2025 09:26

News

Bliss GVS Pharma to announce Quarterly Result

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 12 May 20...

Read more

06 May 2025 11:50

News

Bliss GVS Pharma invokes arbitration proceedings against Pan Pharmaceuticals, Kenya

Bliss GVS Pharma had invoked arbitration proceedings against Pan Pharmaceuticals (Nairobi,...

Read more

03 May 2025 11:27

News

Bliss GVS Pharma schedules board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 Januar...

Read more

22 Jan 2025 09:41

News

Bliss GVS Pharma allots 34,250 equity shares under ESOP

Bliss GVS Pharma has allotted 34,250 equity shares under ESOP on 06 December 2024. With th...

Read more

06 Dec 2024 19:02

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Bliss GVS Pharma Ltd

Which company has a larger market capitalization, Accretion Pharmaceuticals Ltd or Bliss GVS Pharma Ltd?

Market cap of Accretion Pharmaceuticals Ltd is 75 Cr while Market cap of Bliss GVS Pharma Ltd is 1,373 Cr

What are the key factors driving the stock performance of Accretion Pharmaceuticals Ltd and Bliss GVS Pharma Ltd?

The stock performance of Accretion Pharmaceuticals Ltd and Bliss GVS Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Pharmaceuticals Ltd and Bliss GVS Pharma Ltd?

As of May 27, 2025, the Accretion Pharmaceuticals Ltd stock price is INR ₹67.6. On the other hand, Bliss GVS Pharma Ltd stock price is INR ₹130.35.

How do dividend payouts of Accretion Pharmaceuticals Ltd and Bliss GVS Pharma Ltd compare?

To compare the dividend payouts of Accretion Pharmaceuticals Ltd and Bliss GVS Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions